Screener
PBE vs PJP
Invesco Biotechnology & Genome ETF vs Invesco Pharmaceuticals ETF
Key differences
- Over the last 3 years, PJP has delivered higher annualized returns.
Side-by-side comparison
| PBE | PJP | |
|---|---|---|
| Annual cost (TER) | 0.58% | 0.57% |
| Fund size (AUM) | $247M | $334M |
| Since | 2005 | 2005 |
| Dividend yield | 1.09% | 1.01% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +34.1% | +38.9% |
| CAGR 3Y | +10.3% | +14.0% |
| CAGR 5Y | +3.3% | +7.4% |
| Sharpe 3Y | 0.41 | 0.69 |
| Volatility 1Y | 18.63% | 16.19% |
| Max drawdown | -37.84% | -33.95% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to PBE and PJP
Explore further